Age- and gender-related differences in correlations between abdominal obesity and obesity-related metabolic risk factors in Japanese

Internal Medicine

Volumn 48, Issue 7, 2009, Pages 497-502

  Oda, Eiji ^a   Kawa, Ryu ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

Adipose tissue disease; Age; Gender; Metabolic syndrome; Obesity; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADULT; AGE FACTORS; AGED; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; C-REACTIVE PROTEIN; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; LIVER FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; SEX FACTORS;

EID: 67650066271     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1765     Document Type: Article

References (19)

1. Kitamura A, Iso H, Naito Y, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 89: 2533-2539, 1994.
2. Takahashi T, Chikamori T, Yonezawa Y, et al. Prognostic value of serum cholesterol level in Japanse patients with coronary heart disease. Jpn Circ J 61: 139-144, 1997.
3. Miyake Y; Fukuoka Heart Study Group. Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese. Jpn Circ J 64: 103-109, 2000.
4. Nakamura T, Tsubono Y, Kameda-Takemura K, et al. Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a case control study. Jpn Circ J 65: 11-17, 2001.
5. Kawano H, Soejima H, Kojima S, Kitagawa A, Ogawa H. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ J 70: 513-517, 2006.
6. Washio M, Hayashi R. Past history of obesity (overweight by WHO criteria) is associated with an increased risk of nonfatal acute myocardial infarction: A case-control study in Japan. Circ J 68: 41-46, 2004.
7. Shiraishi J, Kohno Y, Sawada T, et al. Relation of obesity to acute myocardial infarction in Japanese patients: -Differences in gender and age-. Circ J 70: 1525-1530, 2006.
8. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
9. Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006.
10. The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 94: 794-809, 2005 (in Japanese).
11. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31: 1285-1293, 2008.
12. Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 118: 124-13, 2008.
13. Chei CL, Iso H, Yamagishi K, Inoue M, Tsugane S; for the JPHC Study Group. Body mass index and weight change since 20 years of age and risk of coronary heart disease among Japanese: the Japan Public Health Center-based Study. Int J Obes 32: 144-151, 2008.
14. Matsuo T, Sairenchi T, Iso H, et al. Age- and gender-specific BMI in terms of the lowest mortality in Japanese general population. Obesity (Silver Spring) 16: 2348-2355, 2008.
15. Sattar N, McConnachie A, Shaper G, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371: 1927-1935, 2008.
16. Kaplan NM. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149: 1514-1520, 1989.
17. Ridker PM, Wilson PWF, Grandy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109: 2818-2825, 2004.
18. Kotronen A, Yki-Jarvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 27-38, 2008.
19. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27: 127-133, 2007.